OS Therapies Incorporated
OSTXOS Therapies Incorporated (OSTX) is a biotechnology company focused on developing innovative gene therapies for rare and serious genetic disorders. The company leverages advanced genetic engineering technologies to create treatments aimed at addressing unmet medical needs.
$1.45 -0.03 (-2.04%)
Company News
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities
Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
Analysts forecast the global oncology drug market to exceed $900 billion by 2034, with biotech firms like Oncolytics, Teva, Citius, ADC Therapeutics, and OS Therapies driving cancer treatment innovation amid potential NCI funding cuts.
